
Seamless Shift Integration
The increasing complexity of drug products brings pharmaceutical companies significant manufacturing challenges arising from the pandemic. This includes disrupting supply chains and requiring changes to business and operational processes to accommodate social distancing, remote work and quarantining. The industry has been in constant transition from producing block-buster medicines towards personalized medicine to break-through vaccines, which for production teams, means there will be increasing variations in the production processes.














































